Type 2 diabetes mellitus in African-American adolescents: Impaired beta-cell function in the face of severe insulin resistance

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 2, 2006, Pages 135-142

  Taha, Doris ^a   Umpaichitra, Vatcharapan ^b   Banerji, Mary Ann ^c   Castells, Salvador ^d  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

^c Downstate Health Sciences University   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Adolescents; African American; Insulin resistance; Insulin secretion; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN; LIPID; PANCREAS ISLET CELL ANTIBODY; TRIACYLGLYCEROL;

ADOLESCENT; AFRICAN AMERICAN; AGE DISTRIBUTION; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CELL FUNCTION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET THERAPY; DISEASE COURSE; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SEXUAL MATURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33644786891     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.2.135     Document Type: Article

References (32)

1. Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288: 1728-1732.
2. Aye T, Levitsky LL. Type 2 diabetes: an epidemic disease in childhood. Curr Opin Pediatr 2003; 15: 411-415.
3. Libman I, Arslanian S. Type 2 diabetes in childhood: the American perspective. Horm Res 2003; 59 (Suppl 1): 69-76.
4. American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics 2000; 105: 671-680.
5. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emergin epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22: 345-354.
6. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996; 128: 608-615.
7. Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986-1998. JAMA 2001; 286: 2845-2848.
8. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2000; 23 (Suppl 1): S4-S19.
9. Pimenta W, Korytkowski M, Mitrakon A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J. Pancreatic beta cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first degree NIDDM relative. JAMA 1995; 273: 1855-1861.
10. Umpaichitra V, Bastian W, Taha D, Banerji MA, AvRuskin TW, Castelis C. C-peptide and glucagon profiles in minority adolescents with type 2 diabetes mellitus. J Clin Endocrinol Metab 2001; 86: 1605-1609.
11. Taha DR, Castells S, Umpaichitra V, Bastian W, Banerji M. Beta-cell response to intravenous glucagon stimulation in African-American and Hispanic adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002; 15: 59-67.
12. DeFronzo RA. The triumvirate: beta cell, muscles, liver: A collusion responsible for NIDDM. Diabetes 1988; 37: 667-687.
13. 2) and triceps skinfold thickness. Am J Clin Nutr 1991; 53: 839-846.
14. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
15. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. Diabetes 1986; 35: 530-545.
16. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-475.
17. Spayd R. Multilayer film elements for clinical analysis. Clin Chem 1978; 24: 1348-1350.
18. ++ precipitation procedure for quantitation of high-density lipoprotein cholesterol. In: Cooper GR, ed. Selected Methods of Clinical Chemistry. Washington, D.C.: American Association for Clinical Chemistry, 1983; 10: 91-99.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
20. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, Renn W, Gerich J. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295-301.
21. Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Co-existence of severe insulin resistance and hyperinsulinemia in preadolescent obese adolescents. Diabetologia 1996; 39: 1489-1497.
22. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane W. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 1989; 114: 963-967.
23. Young-Hyman D, Schlundt D, Herman L, De Luca F, Counts D. Evaluation of the insulin resistance syndrome in 5- to 10-year-old overweight/obese African-American adolescents. Diabetes Care 2001; 24: 1359-1364.
24. Mayor P, Maianu L, Garvey WT. Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes. Effects on glucose transporter gene expression. Diabetes 1992; 41: 274-285.
25. Banerji MA, Lebowitz J, Chaiken RL, Gordon D, Kral JG, Lebovitz HE. Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects. Am J Physiol 1997; 273: E425-432.
26. Arslanian S, Lewy V, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001; 86: 66-71.
27. Gerich J. Insulin resistance is not necessarily an essential component of type 2 diabetes. J Clin Endocrinol Metab 2000; 85: 2113-2115.
28. Kahn SE. The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 4047-4058.
29. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabetes Med 1998; 15: 297-303.
30. Freedman D, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among adolescents and adolescents: the Bogalusa Heart Study. Pediatrics 1999; 103: 1175-1182.
31. Banerji MA, Lebovitz HE. Coronary heart disease risk factor profiles in Black patients with non-insulin-dependent diabetes mellitus: paradoxic patterns. Am J Med 1991; 91: 51-58.
32. Khaw K, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). Br Med J 2001; 322: 15-18.